Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 Diabetes

Phase 4

Completed

• Conditions: Diabetes Mellitus, Type 2
• Interventions: Drug: Insulin LISPRO

• Registration Number: NCT03509324
• Lead Sponsor: Sun Yat-sen University

Brief Summary

The purpose of this study is to investigate and evaluate the significance of intravenous glucose tolerance test in assessment of β-cell function improvement after short course of intensive insulin therapy, trying to illustrate the relationship between fasting plasma glucose and acute insulin release under different stage of type 2 diabetes with poor glycemic control.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-03-01
• Primary Completion: 2015-06-30
• Study Completion: 2015-06-30
• Status Verified: 2018-04
• Study First Submitted: 2018-04-17
• Study First Submitted QC: 2018-04-17
• Last Update Submitted: 2018-04-17
• Study First Posted: 2018-04-26
• Last Update Posted: 2018-04-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 67

Inclusion Criteria

different course of type 2 diabetes with poor glycemic control

Exclusion Criteria

• acute complication or severe comorbidities

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
duration of disease	Insulin LISPRO	different duration of disease receive insulin LISPRO

Primary Outcome Measures

Name	Time	Method
fasting plasma glucose after insulin therapy	10 hour

Trial Locations

Locations (1)

endocrinology department of the first affiliated hospital of Sun Yat-sen University; 🇨🇳 Guangzhou, Guangdong, China